Analysts Set Omega Healthcare Investors Inc (OHI) Target Price at $34.67

Share on StockTwits

Shares of Omega Healthcare Investors Inc (NYSE:OHI) have received an average recommendation of “Hold” from the thirteen research firms that are currently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $34.67.

Several brokerages recently issued reports on OHI. Zacks Investment Research raised Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Wednesday, October 31st. Stifel Nicolaus lowered Omega Healthcare Investors from a “buy” rating to a “hold” rating and set a $39.00 target price on the stock. in a research report on Thursday, February 7th. Scotiabank began coverage on Omega Healthcare Investors in a research report on Thursday, February 7th. They issued a “sector perform” rating and a $39.37 target price on the stock. ValuEngine raised Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research report on Tuesday, November 20th. Finally, Bank of America reaffirmed a “hold” rating on shares of Omega Healthcare Investors in a research report on Monday, November 19th.

In related news, insider Michael Ritz sold 2,000 shares of the stock in a transaction that occurred on Monday, November 19th. The stock was sold at an average price of $35.50, for a total transaction of $71,000.00. Following the completion of the sale, the insider now owns 8,076 shares in the company, valued at approximately $286,698. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Steven J. Insoft sold 50,000 shares of the stock in a transaction that occurred on Thursday, January 31st. The shares were sold at an average price of $40.00, for a total value of $2,000,000.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 86,000 shares of company stock worth $3,321,750. 1.65% of the stock is currently owned by insiders.

Large investors have recently made changes to their positions in the stock. Oregon Public Employees Retirement Fund lifted its position in shares of Omega Healthcare Investors by 3,415.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,757,904 shares of the real estate investment trust’s stock worth $78,000 after acquiring an additional 2,679,443 shares during the period. BlackRock Inc. lifted its position in shares of Omega Healthcare Investors by 5.4% during the 4th quarter. BlackRock Inc. now owns 23,677,458 shares of the real estate investment trust’s stock worth $832,264,000 after buying an additional 1,205,432 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Omega Healthcare Investors by 14.9% during the 2nd quarter. Bank of New York Mellon Corp now owns 5,689,457 shares of the real estate investment trust’s stock worth $176,373,000 after buying an additional 736,393 shares in the last quarter. Renaissance Technologies LLC bought a new position in shares of Omega Healthcare Investors during the 3rd quarter worth approximately $18,889,000. Finally, Federated Investors Inc. PA lifted its position in shares of Omega Healthcare Investors by 19.5% during the 3rd quarter. Federated Investors Inc. PA now owns 3,213,565 shares of the real estate investment trust’s stock worth $105,309,000 after buying an additional 524,162 shares in the last quarter. Hedge funds and other institutional investors own 72.74% of the company’s stock.

Shares of Omega Healthcare Investors stock traded down $2.69 during trading on Friday, hitting $36.57. The stock had a trading volume of 176,869 shares, compared to its average volume of 1,657,602. The company has a quick ratio of 4.17, a current ratio of 4.17 and a debt-to-equity ratio of 1.21. The firm has a market cap of $7.88 billion, a price-to-earnings ratio of 11.07, a price-to-earnings-growth ratio of 6.37 and a beta of 0.52. Omega Healthcare Investors has a fifty-two week low of $25.05 and a fifty-two week high of $40.30.

Omega Healthcare Investors (NYSE:OHI) last announced its earnings results on Monday, February 11th. The real estate investment trust reported $0.31 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.43). The company had revenue of $219.75 million for the quarter, compared to analysts’ expectations of $223.27 million. Omega Healthcare Investors had a net margin of 31.91% and a return on equity of 7.32%. Analysts anticipate that Omega Healthcare Investors will post 2.99 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 15th. Stockholders of record on Thursday, January 31st will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 7.22%. The ex-dividend date of this dividend is Wednesday, January 30th. Omega Healthcare Investors’s dividend payout ratio is 80.00%.

About Omega Healthcare Investors

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

Featured Article: Beta

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Dividend Assets Capital LLC Decreases Position in Plains All American Pipeline, L.P.
Dividend Assets Capital LLC Decreases Position in Plains All American Pipeline, L.P.
Dividend Assets Capital LLC Has $7.50 Million Stake in Hess Midstream Partners LP
Dividend Assets Capital LLC Has $7.50 Million Stake in Hess Midstream Partners LP
Illinois Tool Works Inc.  Stake Decreased by Dividend Assets Capital LLC
Illinois Tool Works Inc. Stake Decreased by Dividend Assets Capital LLC
Inovio Pharmaceuticals  Shares Gap Down to $3.69
Inovio Pharmaceuticals Shares Gap Down to $3.69
Leon G. Cooperman Purchases 275,007 Shares of Ocwen Financial Corp  Stock
Leon G. Cooperman Purchases 275,007 Shares of Ocwen Financial Corp Stock
PerkinElmer, Inc.  Director Sells $524,365.62 in Stock
PerkinElmer, Inc. Director Sells $524,365.62 in Stock


Leave a Reply

© 2006-2019 Ticker Report